Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Sales (2017 - 2025)

Historic Return on Sales for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to 0.16%.

  • Puma Biotechnology's Return on Sales fell 900.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.1% for FY2024, which is 100.0% up from last year.
  • Per Puma Biotechnology's latest filing, its Return on Sales stood at 0.16% for Q3 2025, which was down 900.0% from 0.11% recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Return on Sales peaked at 0.25% during Q3 2024, and registered a low of 0.97% during Q3 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.06% (2025), whereas its average is 0.01%.
  • As far as peak fluctuations go, Puma Biotechnology's Return on Sales plummeted by -3500bps in 2021, and later skyrocketed by 9600bps in 2022.
  • Over the past 5 years, Puma Biotechnology's Return on Sales (Quarter) stood at 0.08% in 2021, then tumbled by -184bps to 0.06% in 2022, then skyrocketed by 366bps to 0.17% in 2023, then increased by 22bps to 0.21% in 2024, then decreased by -22bps to 0.16% in 2025.
  • Its Return on Sales was 0.16% in Q3 2025, compared to 0.11% in Q2 2025 and 0.06% in Q1 2025.